Clinical trial
Feasibility of eLi12 in a Clinical Setting
NCT07306039 is registered in ClinicalTrials.gov with Ole Köhler-Forsberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of eLi12 in a Clinical Setting
- Lead sponsor
- Ole Köhler-Forsberg
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 3, 2025
- Completion date
- December 31, 2027
- Enrollment
- 200 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder (bd)